Effectiveness and tolerability of melatonin was assessed in 32 children (mean age 9.6 + 4.5 years) with chronic sleep initiation and sleep maintenance problems treated naturalistically in a pediatric sleep medicine center. Children received melatonin for an average of 2.1 ± 2.0 months at a final average dose of 2.0 ± 1.2 mg administered 1 hour before bedtime. Twenty-nine (90.6%) children exhibited partial improvement to complete resolution of their sleep problems as measured by sleep latency time and number of awakenings reported by parents. Thus, melatonin may be effective, safe, and well tolerated in the treatment of chronic insomnia in children.
Get full access to this article
View all access options for this article.
References
1.
1. Blader JC, Koplewicz HS, Abikoff H, et al. Sleep problems of elementary school children: a community survey. Arch Pediatr Adolesc Med. 1997;151:473-480.
2.
2. Johnson EO, Howard DC, Breslau N. Trouble sleeping and anxiety/depression in childhood. Psychol Res. 2000;94:93-102.
3.
3. Paavonen EJ, Aronen ET, Moilanen I, et al. Sleep problems in school-aged children: a complimentary view. Acta Paediatr2000;89:223-228.
4.
4. Stein MA, Mendelson J, Obermeyer WH, et al. Sleep and behavior problems in school-aged children. Pediatrics. 2001;107:e60-e60.
5.
5. Chervin R, Dillon J, Bassetti C, et al. Symptoms of sleep disorders, inattention, and hyperactivity in children. Sleep. 1997;20:1185-1192.
6.
6. Simonds JF, Parraga H. Sleep behaviors and disorders in children and adolescents evaluated at psychiatric clinics.JDev Behav Pediatr1984;5:6-10.
7.
7. Quine L. Sleep problems in children with mental handicaps. J Mental Deficiency Res. 1991;35:296-290.
8.
8. Stores G. Sleep studies in children with mental handicap. J Child Psychol Psychiatry. 1992;33:1303-1317.
9.
9. Piazza CC, Fisher WW, Kahng SW. Sleep patterns in children and young adults with mental retardation and severe behavior disorders. Dev Med Child Neurol. 1996;38:335-344.
10.
10. Richdale AL. Sleep problems in autism: prevalence, cause and intervention. Dev Med Child Neurol. 1999;41:60-66.
11.
11. Carskadon MA, Harvey K, Dement WC. Sleep loss in young adolescents. Sleep. 1981;4:299-312.
12.
12. Carskadon MA, Harvey K, Dement WC. Acute restriction of nocturnal sleep in children. Perceptual Motor Skills. 1981;53:103-112.
13.
13. Dahl RE. The impact of inadequate sleep on children's daytime cognitive function. Semin Pediatr Neurol. 1996;3:44-50.
14.
14. Randazzo AC, Muehlbach MJ, Schwitzer PK, Walsh JK. Cognitive function following acute sleep restriction in children ages 10-14. Sleep. 1998;21:861-868.
15.
15. Gozal D. Sleep-disordered breathing and school performance in children. Pediatrics. 1998;102:616-620.
16.
16. Gozal D, Pope DW. Snoring during early childhood and academic performance at ages thirteen and fourteen years. Pediatrics. 2001;107:1394-1399.
17.
17. Dahlitz M, Alvarez B, Vignau J. Delayed sleep phase syndrome response to melatonin. Lancet. 1991;33:1121-1124.
18.
18. Nagtegaal JE, Kerkhof GA, Smits MG, et al. Delayed sleep phase syndrome: a placebo-controlled cross-over study on the effects of melatonin administered five hours before the individual dim light melatonin onset. J Sleep Res. 1998;7:135-143.
19.
19. Folkard S, Arendt J, Clark M. Can melatonin improve shift workers' tolerance of night shift? Preliminary findings. Chronobiol Int. 1993;10:315-320.
20.
20. Petrie K, Dawson A, Thompson L, et al. A double-blind trial of melatonin as a treatment for jet lag in international cabin crew. Biol Psychiatry. 1993;33:526-530.
21.
21. Jan JE, Espezel H, Appleton RE. The treatment of sleep disorders with melatonin. Dev Med Child Neurol. 1994;36:97-107.
22.
22. Bubenik GA, Blask DE, Brown GM, et al. Prospects of the clinical utilization of melatonin. Biol Signals Recept. 1998;7:195-219.
23.
23. Brown GM. Melatonin in psychiatric and sleep disorders: therapeutic implications. Central Nervous System Drugs. 1995;3:209-226.
24.
24. Jan JE, Espezel H, Goulden KJ. Melatonin in sleep disorders in children with neurodevelopmental disabilities. In: Shafii M, Shafii SL, eds. Melatonin in Psychiatric and Neoplastic Disorders. Washington, DC: American Psychiatric Press; 1998:169-188.
25.
25. Jan JE, Hamilton D, Seward N, et al. Clinical trials of controlled-release melatonin in children with sleep-wake cycle disorders. J Pineal Res. 2000;29:34-39.
26.
26. Dodge NN, Wilson GA. Melatonin for treatment of sleep disorders in children with developmental disabilities. J Child Neurol. 2001;16:581-584.
27.
27. Fauteck J, Schmidt H, Lerchl A, et al. Melatonin in epilepsy: first results of replacement therapy and first clinical results. Biol Signals Recept. 1999;8:105-110.
28.
28. Jan JE, Connolly MBC, Hamilton D, et al. Melatonin treatment of nonepileptic myoclonus in children. Dev Med Child Neurol. 1999;41:255-259.
29.
29. Espezel H, Jan JE, O'Donnell ME, et al. The use of melatonin to treat sleepwake-rhythm disorders in children who are visually impaired. J Vis Imp Blind. 1996;90:43-50.
30.
30. Palm L, Blennow G, Wetterberg L. Long-term melatonin treatment in blind children and young adults with circadian sleep-wake disturbances. Dev Med Child Neurol. 1999;39:319-325.
31.
31. Smits MG, Nagtegaal EE, van der Heijden J, et al. Melatonin for chronic sleep onset insomnia in children: a randomized placebo-controlled trial. J Child Neurol. 2001;16:86-92.
32.
32. Jan JE, Donnell ME. Use of melatonin in the treatment of paediatric sleep disorders. J Pineal Res. 1996;21:193-199.
33.
33. Jan JE, Freeman RD, Fast DK. Melatonin treatment of sleep-wake cycle disorders in children and adolescents. Dev Med Child Neurol. 1999;41:491-500.
34.
34. Gordon N. The therapeutics of melatonin: a paediatric perspective. Brain Dev. 2000;22:213-217.
35.
35. Sheldon SH. Pro-convulsant effects of oral melatonin in neurologically disabled children. Lancet. 1998;351:1254-1254.
36.
36. Haimov I, Laudo M, Zisapel N, et al. Sleep disorders and melatonin rhythms in elderly people. Br Med J. 1997;309:167-167.
37.
37. Mc Arthur AJ, Budden SS. Sleep dys-function in Rett syndrome: a trial of exogenous melatonin treatment. Dev Med Child Neurol. 1998;40:186-192.
38.
38. O'Callaghan FJK, Clarke AA, Hancock E, et al. Use of melatonin to treat sleep disorders in tuberous sclerosis. Dev Med Child Neurol. 1999;41:123-126.
39.
39. Picchietti DL, England SJ, Walters AS, et al. Periodic limb movement disorder and restless legs syndrome in children with attention-deficit hyperactivity disorder. J Child Neurol. 1998;13:588-594.
40.
40. Chervin R, Archbold K. Hyperactivity and polysomnographic findings in children evaluated for sleep-disordered breathing. Sleep. 2001;24:313-320.
41.
41. Kennedy CH, Meyer KA. Sleep deprivation, allergy symptoms, and negatively reinforced problem behavior. JAppl Behav Anal. 1996;29:133-135.
42.
42. Petterborg LJ, Thalen BE, Kjellman BF, Wetterborg L. Effect of melatonin replacement on serum hormone rhythms in a patient lacking endogenous melatonin. Brain Res Bull. 1991;27:181-185.
43.
43. Miyamoto A, Oki J, Takahashi S, et al. Serum melatonin kinetics and long-term melatonin treatment for sleep disorders in Rett syndrome. Brain Den. 1999;21:59-62.
44.
44. Zhdanova IV, Wurtman RJ, Wagstaff T. Effects of a low dose of melatonin on sleep in children with Angelman syndrome. J Pediatr Endocrinol Metab. 1999;12:57-67.
45.
45. Carskadon MA, Wolfson AR, Acebo C, et al. Adolescent sleep patterns, circadian timing and sleepiness at a transition to early school days. Sleep. 1999;21:871-881.
46.
46. Dolberg OT, Hirchhmann S, Grunhaus L. Melatonin for the treatment of sleep disturbances in major depressive disorders. Am J Psychiatry. 1998;155:1119-1121.
